DK1150703T3 - Behandling af multipel sclerose med chaperonin 10 og beta-interferon - Google Patents

Behandling af multipel sclerose med chaperonin 10 og beta-interferon

Info

Publication number
DK1150703T3
DK1150703T3 DK00903434T DK00903434T DK1150703T3 DK 1150703 T3 DK1150703 T3 DK 1150703T3 DK 00903434 T DK00903434 T DK 00903434T DK 00903434 T DK00903434 T DK 00903434T DK 1150703 T3 DK1150703 T3 DK 1150703T3
Authority
DK
Denmark
Prior art keywords
chaperonin
multiple sclerosis
treatment
beta interferon
beta
Prior art date
Application number
DK00903434T
Other languages
Danish (da)
English (en)
Inventor
Halle Morton
Alice Cavanagh
Original Assignee
Univ Queensland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Queensland filed Critical Univ Queensland
Application granted granted Critical
Publication of DK1150703T3 publication Critical patent/DK1150703T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/215—IFN-beta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Neurology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Developing Agents For Electrophotography (AREA)
  • Surgical Instruments (AREA)
DK00903434T 1999-01-20 2000-01-20 Behandling af multipel sclerose med chaperonin 10 og beta-interferon DK1150703T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPP8239A AUPP823999A0 (en) 1999-01-20 1999-01-20 A treatment

Publications (1)

Publication Number Publication Date
DK1150703T3 true DK1150703T3 (da) 2006-05-29

Family

ID=3812443

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00903434T DK1150703T3 (da) 1999-01-20 2000-01-20 Behandling af multipel sclerose med chaperonin 10 og beta-interferon

Country Status (12)

Country Link
US (1) US20090214473A1 (OSRAM)
EP (1) EP1150703B1 (OSRAM)
JP (1) JP4691257B2 (OSRAM)
KR (1) KR100694011B1 (OSRAM)
AT (1) ATE313332T1 (OSRAM)
AU (2) AUPP823999A0 (OSRAM)
CA (1) CA2361081C (OSRAM)
DE (1) DE60024967T2 (OSRAM)
DK (1) DK1150703T3 (OSRAM)
ES (1) ES2255484T3 (OSRAM)
PT (1) PT1150703E (OSRAM)
WO (1) WO2000043033A1 (OSRAM)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007517808A (ja) * 2004-01-16 2007-07-05 キュビオ リミテッド Ｔｏｌｌ様受容体誘導性のサイトカインおよびケモカイン分泌のシャペロニン１０調節
BG66458B1 (bg) 2005-03-21 2014-10-31 Иван Иванов Средство за конкурентно инхибиране на ендогенен гама интерферон
KR20080098579A (ko) 2005-08-31 2008-11-11 씨바이오 리미티드 변형된 샤페로닌 10
KR20080075505A (ko) * 2005-10-20 2008-08-18 씨바이오 리미티드 과민증의 치료 방법
CA2644058C (en) * 2006-03-02 2016-08-09 Cbio Limited Regulation of immune responses by modulation of the function of antigen presenting cells
BG66517B1 (bg) 2008-04-08 2016-02-29 Tigo Gmbh Супресор на ендогенния човешки гама - интерферон
US9359421B2 (en) 2008-04-08 2016-06-07 Tigo Gmbh Suppressor of the endogenous interferon-gamma
BG1430U1 (bg) * 2010-06-25 2011-04-29 Иван ИВАНОВ Фармацевтично средство
BG67190B1 (bg) 2017-03-29 2020-11-16 Tigo Gmbh Анти-гама мутантен протеин срещу ендогенния човешки гама интерферон

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2233938T3 (es) * 1993-11-30 2005-06-16 The University Of Queensland Chaperonina 10.
HUT76099A (en) * 1994-05-10 1997-06-30 Immulogic Pharma Corp Compositions and treatment for multiple sclerosis
DE19544768C1 (de) * 1995-11-30 1997-07-10 Rentschler Arzneimittel Verwendung einer Kombination aus Pentoxifyllin mit Typ-I-Interferonen zur Behandlung der Multiplen Sklerose

Also Published As

Publication number Publication date
DE60024967D1 (en) 2006-01-26
ATE313332T1 (de) 2006-01-15
EP1150703B1 (en) 2005-12-21
EP1150703A1 (en) 2001-11-07
US20090214473A1 (en) 2009-08-27
EP1150703A4 (en) 2004-11-10
KR20020002376A (ko) 2002-01-09
DE60024967T2 (de) 2006-08-17
AU771867B2 (en) 2004-04-01
JP4691257B2 (ja) 2011-06-01
CA2361081C (en) 2010-09-21
AU2527100A (en) 2000-08-07
CA2361081A1 (en) 2000-07-27
AUPP823999A0 (en) 1999-02-11
JP2002535286A (ja) 2002-10-22
PT1150703E (pt) 2006-05-31
ES2255484T3 (es) 2006-07-01
WO2000043033A1 (en) 2000-07-27
KR100694011B1 (ko) 2007-03-12

Similar Documents

Publication Publication Date Title
DK1025124T3 (da) Human interferon-alfa-analoge med lav toksicitet
ATE232396T1 (de) Oxydiertes thymosin beta 4
DK486588A (da) Konjungater af cytokininer med immunglobuliner
ATE297200T1 (de) Facettenreiches verfahren zur unterdrückung der vermehrung latenter viren in menschen und tieren
DE69826695D1 (de) Arylharnstoffderivate zur behandlung von inflammatorischen oder immunomodulatorischen erkrankungen
ATE320435T1 (de) Oxazolo-, thiazolo- und selenazolo-(4,5- c)naphthyridin-4-amine und analoge davon
DK0981343T3 (da) Probucolmonoestere til behandling af kardiovaskulær og inflammatorisk sygdom
ES2154252T1 (es) Inhibicion de la quinasa p38 utilizando difenil-ureas simetricas y asimetricas.
CL2010000828A1 (es) Composicion farmaceutica que comprende un conjugado pegilado de interferon alfa y ribavirina, util en la preparacion de un medicamento para las infecciones de hepatitis c cronica.
DK1090645T3 (da) Oral tilförsel af kemisk modificerede proteiner
NO972391D0 (no) 2-substituerte 1,2,5-tiadiazolidin-3-on 1,1-dioksider og preparater og metoder for anvendelse derav
MX9203319A (es) Metodo para la preparacion de cristales de alfa-2 interferona.
DK0391644T3 (da) Arylsubstituerede rhodaninderivater
GEP20002092B (en) 5,6-Dihydropyrone Derivatives Pharma¬ceutical Compositions on the Base of them and Method for Treatment of Antiviral diseases
DK0553294T3 (da) Fremstillingen af sammensætninger til behandlingen af celleproliferationssygdomme
EP1150703A4 (en) TREATMENT OF MULTIPLE SCLEROSIS WITH CHAPERONIN 10 AND BETA-INTERFERON
NO922456L (no) Bcrf1-proteiner som inhibitorer av interferon-gamma
FI922428A0 (fi) Nya 2-amino-5-cyan-1,4- dihydropyridiner, foerfarande foer deras framstaellning och deras anvaendning i laekemedel.
ATE189262T1 (de) Interferon-alpha/beta bindendes protein, seine herstellung und seine enthaltende pharmazeutische zusammensetzungen
DE69000791D1 (de) Therapeutische mittel fuer metabolische knochenkrankheiten.
FR2670780B1 (fr) Derives de 4-(acylamino)benzopyranes, leur preparation et leur application en therapeutique.
EP0579765A4 (en) Method and composition for the treatment of herpes related disorders
DK0907373T3 (da) Anvendelse af synergistiske sammensætninger af IL-12 og IFN-alfa til behandling af infektionssygsomme
IT9041649A0 (it) Protettore della cornea e metodo per il suo ottenimento.
ES1015531Y (es) Jeringuilla perfeccionada de unica utilizacion.